PF Concentration of NO (μM) ± SEM Fold change, with respect to Control TG TG-F Control 5.04 ± 1.21       TG24 11.97 ± 1.56 (+) 2.38#     TG24F 9.29 ± 1.38   (-) 1.29   TG24MF 10.84 ± 5.20   (-) 1.10 (+) 1.17 TG48 13.03 ± 2.13 (+) 2.59     TG48F 10.36 ± 4.28   (-) 1.26   TG48MF 8.69 ± 2.64   (-) 1.50 (-) 1.19 TG72 22.54 ± 9.29 (+) 4.47#     TG72F 19.42 ± 2.31   (-) 1.16   TG72MF 20.00 ± 3.31   (-) 1.13 (+) 1.03 TG96 24.67 ± 1.59 (+) 4.89#     TG96F 13.10 ± 4.38   (-) 1.88   TG96MF 16.60 ± 5.80   (-) 1.49 (+) 1.27 (#: p<0.05 versus Control; *: p<0.05 versus TG; *: p<0.05 versus TG-F)

Table 6: Concentration and fold changes in nitric oxide produced in peritoneal fluid, assayed by Griess Reagent, at 540 nm. With fisetin, there is a 1.29 fold decrease after 24 h, a 1.26 fold decrease after 48 h, a 1.16 fold decrease after 72 h and a 1.88 fold decrease after 96 h. With MCN+fisetin, there is a 1.19 fold decrease after 48 h.